The Sledgehammer in Precision Medicine: Dexamethasone and Immunotherapeutic Treatment of Glioma

Abstract

Understanding dexamethasone’s effect on the immune microenvironment in glioma patients is of key importance. We performed a comprehensive literature review using the NCBI PubMed database for all articles meeting the following search criteria. ((dexamethasone[All Fields]) AND (glioma or glioblastoma)[Title/Abstract]) AND (immune or T cell or B cell or monocyte or neutrophil or macrophage). Forty-three manuscripts were deemed relevant to the topic at hand. Multiple clinical studies have linked dexamethasone use to decreased overall survival while preclinical studies in murine glioma models have demonstrated decreased tumor-infiltrating lymphocytes after dexamethasone administration.

Keywords:

• Dexamethasone
• glioma
• immunotherapy
• PD-1
• lymphocyte

Disclosure statement

No potential conflict of interest was reported by the author(s).